General

“Article: Concerning a previously published practice guidelines article” has been added to your cart. View cart

Showing 225–240 of 1329 results

Article: Clinical practice guidelines for the treatment of rectal cancer patients: The Leuven Rectal Cancer Consensus
€3.03 Add to cart
Article: Clinical presentation, natural history and therapeutic approach in patients with solitary fibrous tumor: a retrospective analysis
€3.03 Add to cart
Article: Clinically meaningful survival benefit with atezolizumab + nab-paclitaxel in previously untreated patients with PD-L1+ metastatic triple negative breast cancer
€3.03 Add to cart
Article: Clinicopathological feature-based risk of recurrence in pT2N0 HR-positive and HER2-negative early breast cancer: a real-world study from the University Hospital Leuven
€3.03 Add to cart
Article: Clinicopathological feature-based risk of recurrence in pT2N0 HR-positive and HER2-negative early breast cancer: a real-world study from the University Hospital Leuven
€3.03 Add to cart
Article: Co-inhibition of BRAF and MEK signalling delays progression in BRAF-mutant metastatic melanoma
€3.03 Add to cart
Article: Combating acquired resistance to EGFR tyrosine kinase inhibitors in lung cancer
€3.03 Add to cart
Article: Combined PD-1 and CTLA4 inhibition delays progression in advanced melanoma
€3.03 Add to cart
Article: Combining EGFR-TKIs and chemotherapy in patients with advanced non-small cell lung cancer: time for a new standard of care?
€3.03 Add to cart
Article: Combining local ablative therapy with immunotherapy
€3.03 Add to cart
Article: Comment on a previously published practice guidelines article
€3.03 Add to cart
Article: Concerning a previously published Introduction
€3.03 Add to cart
Article: Concerning a previously published practice guidelines article
€3.03 Add to cart
Article: Confirmed clinical benefit of BRAF and MEK co-inhibition in BRAF-mutant metastatic melanoma: updated data from coBRIM and BRIM7
€3.03 Add to cart
Article: Confirmed survival benefit of combined BRAF and MEK inhibition in advanced BRAF mutant melanoma
€3.03 Add to cart
Article: Congress Calendar
€3.03 Add to cart

Article: Clinical practice guidelines for the treatment of rectal cancer patients: The Leuven Rectal Cancer Consensus

Article: Clinical presentation, natural history and therapeutic approach in patients with solitary fibrous tumor: a retrospective analysis

Article: Clinically meaningful survival benefit with atezolizumab + nab-paclitaxel in previously untreated patients with PD-L1+ metastatic triple negative breast cancer

Article: Clinicopathological feature-based risk of recurrence in pT2N0 HR-positive and HER2-negative early breast cancer: a real-world study from the University Hospital Leuven

Article: Clinicopathological feature-based risk of recurrence in pT2N0 HR-positive and HER2-negative early breast cancer: a real-world study from the University Hospital Leuven

Article: Co-inhibition of BRAF and MEK signalling delays progression in BRAF-mutant metastatic melanoma

Article: Combating acquired resistance to EGFR tyrosine kinase inhibitors in lung cancer

Article: Combined PD-1 and CTLA4 inhibition delays progression in advanced melanoma

Article: Combining EGFR-TKIs and chemotherapy in patients with advanced non-small cell lung cancer: time for a new standard of care?

Article: Combining local ablative therapy with immunotherapy

Article: Comment on a previously published practice guidelines article

Article: Concerning a previously published Introduction

Article: Concerning a previously published practice guidelines article

Article: Confirmed clinical benefit of BRAF and MEK co-inhibition in BRAF-mutant metastatic melanoma: updated data from coBRIM and BRIM7

Article: Confirmed survival benefit of combined BRAF and MEK inhibition in advanced BRAF mutant melanoma

Article: Congress Calendar